Alopecia areata yaiku kondisi lokal ing ngendi rambut ilang saka awak. Asring, kondisi iki nyebabake bintik botak cilik ing kulit sirah, saben ukuran kaya dhuwit recehan. Penyakit kasebut bisa disebabake dening stres psikologis.
Alopecia areata dipercaya minangka penyakit autoimun sing melibatkan sistem kekebalan folikel rambut. Mekanisme dasare meliputi kegagalan tubuh mengenali sel‑sel sendiri, sehingga terjadi kerusakan folikel rambut yang dimediasi oleh sistem kekebalan.
○ Pengobatan – Obat OTC Sawetara wong kanthi alopecia areata ringan bisa pulih dalam setahun tanpa perawatan. Namun, kebanyakan orang mengalami kambuh di area acak pada kulit kepala. #Hydrocortisone cream
Alopecia areata, also known as spot baldness, is a condition in which hair is lost from some or all areas of the body. Often it results in a few bald spots on the scalp, each about the size of a coin. The disease may cause psychological stress. People are generally otherwise healthy. In a few cases, all the hair on the scalp is lost (alopecia totalis) or all body hair is lost (alopecia universalis) and loss can be permanent.
☆ AI Dermatology — Free Service Ing asil Stiftung Warentest 2022 saka Jerman, kepuasan konsumen karo ModelDerm mung luwih murah tinimbang konsultasi telemedicine sing dibayar.
Alopecia areata katon ing mburi sirah. Ing kasus sing umum, lesi muncul kanthi mendadak, permukaane rata, lan ukurané 2–3 cm.
Alopecia areata minangka kondisi ing ngendi sistem kekebalan awak nyerang folikel rambut, nyebabake rambut rontog sacara sementara tanpa parut. Bisa katon minangka patch rambut rontog utawa mengaruhi kabeh kulit sirah utawa awak, nyebabake udakara 2 % wong ing sawetara tahapan urip. Panyebab utama katon minangka karusakan ing proteksi alam ing sekitar folikel rambut. Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata minangka kondisi ing ngendi sistem kekebalan nyerang folikel rambut, nyebabake rambut rontog ing kulit sirah lan bagian awak liyane. Iki mengaruhi udakara 2% wong ing saindenging jagad. Sanajan bisa kedadeyan ing umur apa wae, luwih umum ing bocah tinimbang wong diwasa (1,92% vs. 1,47%). Wong wadon, utamane sing umure luwih saka 50 taun, cenderung ngalami luwih akeh tinimbang lanang. Nyuntikake kortikosteroid langsung menyang wilayah sing kena pengaruh wis nuduhake asil sing luwih apik tinimbang ditrapake sacara topikal. Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata dipercaya minangka penyakit autoimun sing melibatkan sistem kekebalan folikel rambut. Mekanisme dasare meliputi kegagalan tubuh mengenali sel‑sel sendiri, sehingga terjadi kerusakan folikel rambut yang dimediasi oleh sistem kekebalan.
○ Pengobatan – Obat OTC
Sawetara wong kanthi alopecia areata ringan bisa pulih dalam setahun tanpa perawatan. Namun, kebanyakan orang mengalami kambuh di area acak pada kulit kepala.
#Hydrocortisone cream
○ Pengobatan
Injeksi steroid intralesional adalah perawatan yang paling efektif. Imunoterapi dapat dipertimbangkan bila area yang terkena pada kulit kepala luas.
#Triamcinolone intralesional injection
#DPCP immunotherapy